as legal lead for digital, data and privacy agreements, along with Business Associate Agreements as required under HIPAA.... Legal Research: Stay updated on legal and regulatory developments in the medical device industry and provide recommendations...
Associate Director of Regulatory Affairs-Chemistry, Manufacturing, and Controls (RA-CMC) in Japan will be responsible... for leading and providing Japan CMC regulatory support for the clinical and commercial product portfolio, which means managing...
Job Summary : The Japan Clinical Monitoring team is growing, and we are seeking a full-time an Associate Director... : Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services...
Job Summary The Japan Clinical Monitoring team is growing, and we are seeking a full-time an Associate Director... Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services...
【募集Summary】 Sr Records Management(RM) Associateは、IQVIAにおけるTMF Managementにおいて、TMF におけるDocument Processing(Imaging QC...を産前産後休暇とする ■育児休業:子供が1歳2ヵ月に達するまでを限度とし、本人の申し出た期間休業可能(やむを得ない場合は3歳まで可) ■介護休業 ■女性特別休暇 IQVIA is a leading global provider of clinical...
part. Responsible for developing staff(Senior ClinicalResearchAssociate and ClinicalResearchAssociate) capabilities... with clinicalresearch 【能力 / Skill-set】 <必須 / Mandatory> Effective in leading, motivating and empowering others in order...
and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It... material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development...
about our company and new grads’ career opportunities at Medpace Japan. ClinicalResearchAssociate (CRA) and other professional roles... will be provided should you be selected to attend. Responsibilities ClinicalResearchAssociate (CRA) - join our growing team...
Mukesh Ambani-owned RIL reported a 5 per cent drop in consolidated net profit, totaling ₹15,138 crore for the first quarter ended June 2024, compared to ₹16,011 crore in the same period last year. Continue Reading »
Sebi's initiative could provide brokers with additional revenue, but concerns arise regarding compliance complexities and potential reluctance from brokers to adopt the new trading model. Continue Reading »
The Garuda Construction IPO saw strong demand, with full subscription on the first day. It comprises new equity shares and an OFS, valued at ₹264 crore. Proceeds will fund working capital and acquisitions. The bidding period is from October 8 to 10. Continue Reading »
Top Gainers and Losers Today : The Sensex gained 584.81 points, or 0.72, to settle at 81050.0, while the Nifty gained 217.4 points, or 0.88, to close at 24795.75. Continue Reading »
HDFC Securities maintains a 'sell' recommendation on Vinati Organics due to high valuations and a target price of ₹1,491. Despite this, the company is expected to grow significantly over the long term through new projects and product expansions. Continue Reading »
The Nifty 50 closed the session with a gain of 0.88%, finishing above the 25,000 mark at 25,013 points. Similarly, the Sensex wrapped up the day with a 0.7% increase, settling at 81,634 points. Continue Reading »
The $3 billion IPO will open for subscriptions for big institutional investors on Oct. 14, and invite bids from retail and other categories during Oct. 15-17 Continue Reading »